logo
HIV delivers its infectious cargo concealed within an endosome
Targeting Trojan Horse leukocytes for HIV prevention
Delivering integrated HIV services: time for a client-centred approach to meet the sexual and reproductive health needs of people living with HIV?
APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load
Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin α4β7
HLA-B molecules target more conserved regions of the HIV-1 proteome
Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery
The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
Response to planned treatment interruptions in HIV infection varies across childhood
Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men
Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors
The protease inhibitor combination lopinavir/ritonavir does not decrease insulin secretion in healthy, HIV-seronegative volunteers
Transmission networks of HIV-1 among men having sex with men in the Netherlands
Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital
Egocentric network data provide additional information for characterizing an individual's HIV risk profile
Polygyny and the spread of HIV in sub-Saharan Africa: a case of benign concurrency
Combined antiretroviral therapy is effective on blood plasma HIV-1-RNA: what about semen HIV-1-RNA levels?
Concurrency is more complex than it seems
N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations
Sensitivity of V75I HIV-1 reverse transcriptase mutant selected in vitro by acyclovir to anti-HIV drugs
Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV–tuberculosis patients
HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis